FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of the company’s listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. REUTERS/Brendan McDermid
(Reuters) – Johnson & Johnson (JNJ.N) said on Tuesday it will pay $20.4 million to settle claims by two Ohio counties in a lawsuit that accused the drugmaker of contributing to an U.S. opioid addiction epidemic.
The company said in a statement the settlement removes it from a federal trial against multiple manufacturers and distributors scheduled to begin on Oct. 21..
J&J will pay $10 million to Cuyahoga and Summit counties, reimburse $5 million of their legal and other expenses and provide $5.4 million to non-profit organizations that run opioid-related programs in the counties.
On Monday, Mallinckrodt Plc (MNK.N) finalized a $24 million settlement agreement with the same two counties.
Remaining defendants in the Oct. 21 trial include McKesson Corp (MCK.N), AmerisourceBergen (ABC.N), Cardinal Health (CAH.N), Teva Pharmaceutical Industries Ltd (TEVA.TA) , Walgreens Boots Alliance Inc (WBA.O) and Henry Schein Inc (HSIC.O).
Earlier in the year, an Oklahoma judge ordered Johnson & Johnson to pay $572.1 million to the state for its part in fueling an opioid epidemic by deceptively marketing addictive painkillers.
Reporting by Shubham Kalia in Bengaluru; additional reporting by Nate Raymond; Editing by Muralikumar Anantharaman and Cynthia Osterman